Related Experiment Video
Updated: Jul 14, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
International Utah cardiac recovery symposium (U-CARS) 2025:translational and basic science proceedings
Joseph R Visker1,2, Eleni Tseliou1,2,3, Konstantinos Drosatos4
1Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, USA.
Heart Failure Reviews
|April 14, 2026
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

